U.S. support for COVID patent waiver will push WTO talks, says WTO chief
Reuters
Published May 07, 2021 05:25AM ET
ROME (Reuters) - A United States' proposal to discuss waiving patent protections for COVID-19 vaccines will intensify talks on the issue within the World Trade Organisation, the WTO director general said on Friday.
Speaking at an online conference, Ngozi Okonjo-Iweala said there were arguments for and against a waiver, but she was "sure (the proposal) will give impetus" to negotiations.
Aside from the patent issue, the WTO chief said there were other aspects that needed to be addressed to improve vaccine supplies, such as reducing export restrictions so that supply chains can work efficiently.
At the event organised by the European University Institute in Florence, Okonjo-Iweala said it was also necessary to increase production capacity in emerging countries, noting that Africa currently imports almost all its vaccines.
She said she hoped WTO members would "come together" to address all these issues to help increase vaccine volumes.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.